Prenetics sells ownership of ACT Genomics for $71.78 million to strengthen Bitcoin financial strategy

Odaily Planet Daily News: Nasdaq listed company Prenetics announced that it has reached a final agreement to transfer its ownership of ACT Genomics Holdings Company Limited to Delta Electronics Co., Ltd. for approximately $71.78 million. The divestment of ACT Genomics significantly enhances Prenetics' financial foundation, with an estimated cash reserve of approximately $86 million and estimated cash and short-term assets of $117 million. The company maintains a debt free balance sheet with zero liabilities, allowing it to explore other financial management options, including digital asset adoption and Bitcoin financial strategies. （Globenewswire）